Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7873203rdf:typepubmed:Citationlld:pubmed
pubmed-article:7873203lifeskim:mentionsumls-concept:C0024109lld:lifeskim
pubmed-article:7873203lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:7873203lifeskim:mentionsumls-concept:C1273518lld:lifeskim
pubmed-article:7873203lifeskim:mentionsumls-concept:C0016030lld:lifeskim
pubmed-article:7873203lifeskim:mentionsumls-concept:C0021755lld:lifeskim
pubmed-article:7873203lifeskim:mentionsumls-concept:C0012472lld:lifeskim
pubmed-article:7873203lifeskim:mentionsumls-concept:C0387583lld:lifeskim
pubmed-article:7873203lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:7873203lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:7873203lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:7873203pubmed:issue3lld:pubmed
pubmed-article:7873203pubmed:dateCreated1995-4-5lld:pubmed
pubmed-article:7873203pubmed:abstractTextBecause interleukin-1 beta (IL-1 beta) increases the synthesis of prostaglandin E2 (PGE2) in human lung fibroblasts, the effect of IL-1 beta on the expression of two isozymes of cyclooxygenase (cyclooxygenase-1 and -2) in human embryonic lung fibroblasts (IMR-90) was investigated in terms of three parameters (PGE2 release, cyclooxygenase activity, and mRNA). When the cells were incubated with IL-1 beta, both the PGE2 release to the culture medium and the cyclooxygenase activity in the cell lysate increased in a dose- and time-dependent manner, and both were inhibited by NS-398 (a cyclooxygenase-2-specific inhibitor). Dexamethasone and interleukin-4 (IL-4) inhibited the IL-1 beta-induced PGE2 synthesis; the former inhibited the IL-1 beta-induced cyclooxygenase activity whereas the latter failed. As analyzed by Northern blot, cyclooxygenase-1 mRNAs (3.0 Kb and 5.0 Kb) were detected with resting cells and did not increase by the addition of IL-1 beta. In contrast, the cyclooxygenase-2 mRNA (4.4 Kb) was undetectable with resting cells, but was increased dramatically up to 4 to 8 h by the addition of IL-1 beta. Dexamethasone inhibited the IL-1 beta-induced mRNA expression of cyclooxygenase-2 whereas IL-4 failed. These results indicate that IL-1 beta induces cyclooxygenase-2 rather than cyclooxygenase-1 in IMR-90 cells and this induction is responsible for the augmentation of PGE2 production stimulated with IL-1 beta. However, the inhibition of the IL-1 beta-induced PGE2 synthesis by IL-4 was not mediated by the down-regulation of cyclooxygenase-2.lld:pubmed
pubmed-article:7873203pubmed:languageenglld:pubmed
pubmed-article:7873203pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7873203pubmed:citationSubsetIMlld:pubmed
pubmed-article:7873203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7873203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7873203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7873203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7873203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7873203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7873203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7873203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7873203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7873203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7873203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7873203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7873203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7873203pubmed:statusMEDLINElld:pubmed
pubmed-article:7873203pubmed:monthMarlld:pubmed
pubmed-article:7873203pubmed:issn1044-1549lld:pubmed
pubmed-article:7873203pubmed:authorpubmed-author:EndoTTlld:pubmed
pubmed-article:7873203pubmed:authorpubmed-author:UedaNNlld:pubmed
pubmed-article:7873203pubmed:authorpubmed-author:HayashiYYlld:pubmed
pubmed-article:7873203pubmed:authorpubmed-author:YamamotoSSlld:pubmed
pubmed-article:7873203pubmed:authorpubmed-author:OguraTTlld:pubmed
pubmed-article:7873203pubmed:authorpubmed-author:OgushiFFlld:pubmed
pubmed-article:7873203pubmed:authorpubmed-author:SoneSSlld:pubmed
pubmed-article:7873203pubmed:authorpubmed-author:TaketaniYYlld:pubmed
pubmed-article:7873203pubmed:issnTypePrintlld:pubmed
pubmed-article:7873203pubmed:volume12lld:pubmed
pubmed-article:7873203pubmed:ownerNLMlld:pubmed
pubmed-article:7873203pubmed:authorsCompleteYlld:pubmed
pubmed-article:7873203pubmed:pagination358-65lld:pubmed
pubmed-article:7873203pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7873203pubmed:meshHeadingpubmed-meshheading:7873203-...lld:pubmed
pubmed-article:7873203pubmed:meshHeadingpubmed-meshheading:7873203-...lld:pubmed
pubmed-article:7873203pubmed:meshHeadingpubmed-meshheading:7873203-...lld:pubmed
pubmed-article:7873203pubmed:meshHeadingpubmed-meshheading:7873203-...lld:pubmed
pubmed-article:7873203pubmed:meshHeadingpubmed-meshheading:7873203-...lld:pubmed
pubmed-article:7873203pubmed:meshHeadingpubmed-meshheading:7873203-...lld:pubmed
pubmed-article:7873203pubmed:meshHeadingpubmed-meshheading:7873203-...lld:pubmed
pubmed-article:7873203pubmed:meshHeadingpubmed-meshheading:7873203-...lld:pubmed
pubmed-article:7873203pubmed:meshHeadingpubmed-meshheading:7873203-...lld:pubmed
pubmed-article:7873203pubmed:meshHeadingpubmed-meshheading:7873203-...lld:pubmed
pubmed-article:7873203pubmed:meshHeadingpubmed-meshheading:7873203-...lld:pubmed
pubmed-article:7873203pubmed:meshHeadingpubmed-meshheading:7873203-...lld:pubmed
pubmed-article:7873203pubmed:meshHeadingpubmed-meshheading:7873203-...lld:pubmed
pubmed-article:7873203pubmed:meshHeadingpubmed-meshheading:7873203-...lld:pubmed
pubmed-article:7873203pubmed:meshHeadingpubmed-meshheading:7873203-...lld:pubmed
pubmed-article:7873203pubmed:meshHeadingpubmed-meshheading:7873203-...lld:pubmed
pubmed-article:7873203pubmed:meshHeadingpubmed-meshheading:7873203-...lld:pubmed
pubmed-article:7873203pubmed:meshHeadingpubmed-meshheading:7873203-...lld:pubmed
pubmed-article:7873203pubmed:meshHeadingpubmed-meshheading:7873203-...lld:pubmed
pubmed-article:7873203pubmed:meshHeadingpubmed-meshheading:7873203-...lld:pubmed
pubmed-article:7873203pubmed:year1995lld:pubmed
pubmed-article:7873203pubmed:articleTitleInduction of cyclooxygenase-2 is responsible for interleukin-1 beta-dependent prostaglandin E2 synthesis by human lung fibroblasts.lld:pubmed
pubmed-article:7873203pubmed:affiliationThird Department of Internal Medicine, School of Medicine, Tokushima University, Japan.lld:pubmed
pubmed-article:7873203pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7873203pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:7873203pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7873203lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7873203lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7873203lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7873203lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7873203lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7873203lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7873203lld:pubmed